MDS is a group of conditions that affect new blood cell production. With MDS, blood cells in the bone marrow are abnormal, which leads to fewer healthy red blood cells, white blood cells, and ...

Myelodysplastic syndromes, also called myelodysplasia or MDS, is the name for a group of conditions that cause the number of normal blood cells to drop. In these syndromes, the bone marrow does not ...

Improvements in the classification of myelodysplastic syndrome, MDS, based on varying characteristics in the disease have better defined prognosis and helped patients and doctors make ...

Myelodysplastic syndromes (MDS) are a group of blood cancers that affect the bone marrow and can result in a low levels of blood cells. When MDS affects red blood cells, it can lead to anemia in some ...

Deep in the bone marrow lies the reason for blood disorders classified as myelodysplastic syndromes—stem cells gone awry. In the mid-1970s, a group of pathologists and clinicians from around the ...

Rytelo (imetelstat) is a medicine used to treat myelodysplastic syndromes (MDS). MDS is a rare group of disorders that affect your blood cells. Most people who get MDS are 65 years of age or older, ...

Fatigue is a common symptom in myelodysplastic syndromes (MDS), even during treatment. While you may not be able to completely eliminate feelings of exhaustion, lifestyle strategies can help you ...

The prognostic impact of monocytosis in patients with myelodysplastic syndromes (MDS) is not well-studied and not been clearly defined. Patients with MDS and monocytosis had a shorter overall survival ...